Abstract
All the development phases of a new radiopharmaceutical from its design to its clinical trial and final approval for general clinical use was reviewed in 1983 (1). Products of biological origins presents special problems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference
Safety and Efficacy of Radiopharmaceuticals. Kristensen K, Nørbygaard E (eds) Nijhof, Hague, 1984.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishers, Dordrecht
About this chapter
Cite this chapter
Kristensen, K., Nørbygaard, E. (1987). Introduction. In: Kristensen, K., Nørbygaard, E. (eds) Safety and Efficacy of Radiopharmaceuticals 1987. Developments in Nuclear Medicine, vol 14. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3375-0_1
Download citation
DOI: https://doi.org/10.1007/978-94-009-3375-0_1
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8016-3
Online ISBN: 978-94-009-3375-0
eBook Packages: Springer Book Archive